Mink Brook entities report 190,596 shares in Ekso Bionics (NASDAQ: EKSO)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Mink Brook reporting persons report beneficial ownership of 190,596 shares (5.4%) of Ekso Bionics common stock. As of the close of business on April 8, 2026, Mink Brook Partners LP held 190,596 shares. The filing states shared voting and shared dispositive power among Mink Brook Capital GP LLC, Mink Brook Asset Management LLC, and William Mueller. The percentage is calculated using 3,563,381 shares outstanding as of February 23, 2026 disclosed in the company’s Form 10-K; the filers include a disclaimer of beneficial ownership except to the extent of pecuniary interest.
Positive
- None.
Negative
- None.
Key Figures
Shares held by Mink Brook Partners LP: 190,596 shares
Percent of class: 5.4%
Shares outstanding used for calculation: 3,563,381 shares
3 metrics
Shares held by Mink Brook Partners LP
190,596 shares
held as of April 8, 2026
Percent of class
5.4%
calculated using 3,563,381 shares outstanding as of February 23, 2026
Shares outstanding used for calculation
3,563,381 shares
as of February 23, 2026 (Form 10-K)
Key Terms
beneficially owned, shared dispositive power, Section 13(d)
3 terms
beneficially owned regulatory
"Amount beneficially owned: As of the close of business on April 8th, 2026"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Section 13(d) regulatory
"deemed to constitute an admission ... for purposes of Section 13(d)"
FAQ
What stake does Mink Brook Partners hold in EKSO?
Mink Brook Partners LP holds 190,596 shares, equal to 5.4% of Ekso Bionics. The percentage uses 3,563,381 shares outstanding as of February 23, 2026 per the Form 10-K; the position is reported as shared voting and dispositive power.
What date is the ownership based on in the Schedule 13G filing?
The ownership amount is reported as of the close of business on April 8, 2026. The percentage calculation references 3,563,381 shares outstanding as of February 23, 2026, per the company’s Form 10-K.
Is the reporting person admitting beneficial ownership under Section 13(d)?
No. The filing explicitly disclaims that William Mueller and Mink Brook Capital GP LLC are the beneficial owners for purposes of Section 13(d), except to the extent of any pecuniary interest, per the filing language.